FOLD Q2 2018 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21M+197.7% YoY

Gross Profit

$18M85.3% margin

Operating Income

-$47M-220.2% margin

Net Income

-$62M-290.2% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+27.6%

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$58M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$826M

Total Liabilities

$264M

Stockholders' Equity

$562M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$7M	+197.7%
Gross Profit	$18M	$6M	+198.1%
Operating Income	-$47M	-$47M	+0.3%
Net Income	-$62M	-$48M	-28.5%